Menu
1-702-720-6310 info@microcapspecualtors.com

ASIT biotech Will Publish the Results of the Phase 3 Clinical Trial with Its gp-ASIT+™ Product Candidate for … – Business Wire (press release)

ASIT biotech Will Publish the Results of the Phase 3 Clinical Trial with Its gp-ASIT+™ Product Candidate for
Business Wire (press release)
ASIT biotech (Paris:ASIT) (BSE:ASIT) (BE0974289218), a Belgian clinical-stage biopharmaceutical company focused on the research, development and future commercialization of breakthrough immunotherapy products for the treatment of allergies, …

and more »

Search